Whalesbook
Growth and Valuation Questions
Rays of Belief, the parent of the Mom's Belief brand for neurodevelopmental disorder (NDD) interventions, is preparing for major expansion with a pre-IPO funding round and an upcoming Initial Public Offering (IPO). The company raised ₹2.3 crore from Myong Zin Park at a ₹622 crore valuation. SEBI has cleared its IPO filings, with an updated prospectus submitted. The proposed IPO aims to raise ₹174 crore through 60 lakh new shares. This high pre-IPO valuation, compared to its ₹36.6 crore revenue in FY25, signals strong expectations for growth and its position in the NDD sector. The NDD services market in India was valued at ₹5,246 crore as of March 2025, with developmental delays therapy expected to grow by about 11% annually.
Expansion Funding and Plans
Capital from the pre-IPO round and the upcoming public offering will fund its expansion. ₹57.6 crore is set aside for new centers and technology in India. More funds will support existing Indian centers via lease payments (₹14.4 crore) and boost the US subsidiary, Mom's Belief US Inc., with ₹10.1 crore for leases and licenses. The US acquisition, which added ₹20.59 crore to revenue in six months, offers a base for cross-selling and entering developed markets. Another ₹10.2 crore is for brand awareness and outreach. The rest is for potential acquisitions and general corporate needs. Management plans to open 414 new centers between FY27 and FY29, using an asset-light model with short leases and quick breakeven times of 8-12 months.
Market Landscape and Competition
Rays of Belief operates in a growing but fragmented NDD care market. It competes with specialized firms like Behavioral Health Works, Heba, and Aris4Autism, plus many regional players. Mom's Belief stands out with a standardized, centralized care approach and its asset-light expansion strategy, focusing on Tier-2 and Tier-3 cities with lower costs. The healthcare IPO market in 2025 saw many listings, with some strong performers but also smaller deals and weaker IPO returns by year-end. India's stock market had a record year in 2025, driven by local investors, with healthcare remaining popular due to steady demand and growth prospects. For valuation, multiples like EV/EBITDA are often favored over P/E, especially considering lease accounting standards.
Key Risks and Challenges
Despite strong market demand and expansion plans, significant risks need attention. The pre-IPO valuation of ₹622 crore for ₹36.6 crore in FY25 revenue implies a high revenue multiple, possibly above benchmarks in similar childcare sectors (typically 0.5x-1.5x revenue or 2x-4x EBITDA). The ambitious expansion relies heavily on IPO funds, posing execution risks and dependence on market conditions for future capital. While short leases help rapid scaling, they also mean ongoing operational costs. Moreover, the NDD sector struggles with a shortage of specialized clinical staff. This could increase costs and reduce profit margins, with clinical staff turnover at 4.51%. Rays of Belief's EBITDA margin expanded to 10.08% in H1 FY26 but remains modest, showing pressure to turn revenue growth into steady profit. The US acquisition brings currency and integration risks, and its large revenue share highlights the segment's importance for growth. Investors must weigh the challenges of managing a wide network and maintaining high growth in a competitive, talent-scarce market.
Company Aims
Rays of Belief aims to become India's first listed, scaled neurodevelopmental care platform. Its strategy focuses on its asset-light model, expanding geographical reach, and building brand awareness. Plans to open 414 new centers by FY29 show management's confidence in market demand and operational scalability. IPO funds are crucial for these plans, including innovation through Centers for Excellence and Research, and training academies to address talent shortages. Strong sector growth drivers, such as rising diagnosis rates and increased awareness, support continued demand.